Biomark Diagnostics Inc. (BMKDF)
OTCMKTS
· Delayed Price · Currency is USD
0.134
0.00 (0.00%)
Dec 24, 2024, 4:00 PM EST
Biomark Diagnostics Revenue
Biomark Diagnostics had revenue of 38.35K CAD in the quarter ending September 30, 2024, a decrease of -8.97%. This brings the company's revenue in the last twelve months to 158.01K, down -0.31% year-over-year. In the fiscal year ending March 31, 2024, Biomark Diagnostics had annual revenue of 163.22K with 6.34% growth.
Revenue (ttm)
158.01K CAD
Revenue Growth
-0.31%
P/S Ratio
n/a
Revenue / Employee
n/a
Employees
n/a
Market Cap
10.30M USD
Revenue Chart
* This company reports financials in CAD.
Revenue History
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
Company Name | Revenue |
---|---|
Sandoz Group AG | 10.11B |
Telix Pharmaceuticals Limited | 430.80M |
Elekta AB (publ) | 1.66B |
Ryman Healthcare Limited | 458.44M |
Verano Holdings Corp. | 897.57M |
Vireo Growth Inc. | 98.53M |
Medexus Pharmaceuticals Inc. | 104.76M |
Biomark Diagnostics News
- 16 days ago - BioMark's Liquid Biopsy Platform Takes A Major Step Forward in Breast Cancer Diagnosis with AI-powered ER Status Prediction - Newsfile Corp
- 7 weeks ago - BioMark Expands Its Liquid Biopsy Platform with Two Groundbreaking Publications in Breast Cancer Detection - Newsfile Corp
- 3 months ago - BioMark Diagnostics and Principal Investigators Publish an Important Approach Using Metabolomics and ML to Identify Biomarkers for NEN - Newsfile Corp
- 3 months ago - BioMark Diagnostics Completes Testing of over 5,400 Subjects as Part of a Validation Study for Early Lung Cancer Detection - Newsfile Corp
- 4 months ago - Biomark Diagnostics to Showcase Innovative Liquid Biopsy Technology at H.C. Wainwright's 26th Annual Global Investment Conference in New York - Newsfile Corp
- 5 months ago - The U.S. Patent and Trademark Office Grants BioMark Patent That Expands Its Claims Covering Its Legacy Liquid Biopsy Assay - Newsfile Corp
- 5 months ago - BioMark Diagnostics Announces Presentation of Promising Glioblastoma Research at 2024 GPEN Conference - Newsfile Corp
- 9 months ago - BioMark Announces Warrant Extension and Granting of Options - Newsfile Corp